Mari‐Ann Wallander

4.3k total citations
95 papers, 3.2k citations indexed

About

Mari‐Ann Wallander is a scholar working on Gastroenterology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mari‐Ann Wallander has authored 95 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Gastroenterology, 38 papers in Surgery and 16 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mari‐Ann Wallander's work include Gastroesophageal reflux and treatments (34 papers), Eosinophilic Esophagitis (26 papers) and Helicobacter pylori-related gastroenterology studies (20 papers). Mari‐Ann Wallander is often cited by papers focused on Gastroesophageal reflux and treatments (34 papers), Eosinophilic Esophagitis (26 papers) and Helicobacter pylori-related gastroenterology studies (20 papers). Mari‐Ann Wallander collaborates with scholars based in Sweden, Spain and United States. Mari‐Ann Wallander's co-authors include Saga Johansson, Luis A. Garcı́a Rodrı́guez, Ana Ruigómez, Luis A. García‐Rodríguez, Kurt Svärdsudd, Lucía Cea Soriano, Kristian Hveem, Roar Johnsen, Tove Jörgensen and Kurt Svärdsudd and has published in prestigious journals such as Gastroenterology, PLoS ONE and Neurology.

In The Last Decade

Mari‐Ann Wallander

95 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mari‐Ann Wallander Sweden	37	1.2k	1.1k	575	449	390	95	3.2k
Saga Johansson Sweden	44	1.8k 1.5×	1.1k 1.0×	1.8k 3.1×	481 1.1×	791 2.0×	149	5.4k
Colleen Metge Canada	33	1.4k 1.2×	393 0.4×	347 0.6×	487 1.1×	246 0.6×	110	3.8k
Bo Israelsson Sweden	29	1.5k 1.3×	319 0.3×	1.4k 2.4×	359 0.8×	374 1.0×	65	4.7k
Kurt Svärdsudd Sweden	24	530 0.5×	565 0.5×	418 0.7×	196 0.4×	132 0.3×	56	2.2k
Patrick C. Souverein Netherlands	35	717 0.6×	177 0.2×	822 1.4×	501 1.1×	521 1.3×	201	4.4k
Rhonda L. Bohn United States	28	695 0.6×	218 0.2×	729 1.3×	225 0.5×	272 0.7×	83	3.5k
Virginia Pate United States	29	3.0k 2.6×	476 0.4×	387 0.7×	610 1.4×	440 1.1×	105	4.9k
Kristijan H. Kahler United States	27	480 0.4×	329 0.3×	454 0.8×	250 0.6×	164 0.4×	72	2.9k
Andrea Roalfe United Kingdom	32	589 0.5×	469 0.4×	2.6k 4.5×	817 1.8×	425 1.1×	98	5.3k
William O. Williford United States	30	1.1k 1.0×	692 0.6×	523 0.9×	578 1.3×	1.0k 2.6×	60	4.6k

Countries citing papers authored by Mari‐Ann Wallander

Since Specialization

Citations

This map shows the geographic impact of Mari‐Ann Wallander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mari‐Ann Wallander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mari‐Ann Wallander more than expected).

Fields of papers citing papers by Mari‐Ann Wallander

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mari‐Ann Wallander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mari‐Ann Wallander. The network helps show where Mari‐Ann Wallander may publish in the future.

Co-authorship network of co-authors of Mari‐Ann Wallander

This figure shows the co-authorship network connecting the top 25 collaborators of Mari‐Ann Wallander. A scholar is included among the top collaborators of Mari‐Ann Wallander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mari‐Ann Wallander. Mari‐Ann Wallander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rodrı́guez, Luis A. Garcı́a, Mari‐Ann Wallander, Leif Friberg, et al.. (2020). Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practice. Expert Opinion on Drug Safety. 19(11). 1513–1520. 4 indexed citations

Wallander, Mari‐Ann, Thorne Wallman, Annika Rosengren, et al.. (2019). Age and sex related self-reported symptoms in a general population across 30 years: Patterns of reporting and secular trend. PLoS ONE. 14(2). e0211532–e0211532. 18 indexed citations

Martín‐Merino, Elisa, et al.. (2015). The incidence of hysterectomy, uterus-preserving procedures and recurrent treatment in the management of uterine fibroids. European Journal of Obstetrics & Gynecology and Reproductive Biology. 194. 147–152. 13 indexed citations

Ruigómez, Ana, A. P. S. Hungin, Per Lundborg, et al.. (2011). Treatment patterns in paediatric patients with a new diagnosis of gastroesophageal reflux disease. European Journal of Gastroenterology & Hepatology. 23(3). 232–237. 5 indexed citations

Rodríguez, L.A. García, et al.. (2010). Characteristics and drug utilization patterns of new users of rosuvastatin and other statins in four countries.. PubMed. 58(6). 611–22. 1 indexed citations

Wallander, Mari‐Ann, et al.. (2009). Age-specific symptom prevalence in women 35–64 years old: A population-based study. BMC Public Health. 9(1). 37–37. 38 indexed citations

Rodrı́guez, Luis A. Garcı́a, et al.. (2009). Chronic Obstructive Pulmonary Disease in UK Primary Care: Incidence and Risk Factors. COPD Journal of Chronic Obstructive Pulmonary Disease. 6(5). 369–379. 40 indexed citations

Jansson, Catarina, Mari‐Ann Wallander, Saga Johansson, Roar Johnsen, & Kristian Hveem. (2009). Stressful psychosocial factors and symptoms of gastroesophageal reflux disease: a population-based study in Norway. Scandinavian Journal of Gastroenterology. 45(1). 21–29. 39 indexed citations

Ruigómez, Ana, Mari‐Ann Wallander, Saga Johansson, & Luis A. Garcı́a Rodrı́guez. (2008). Irritable Bowel Syndrome and Gastroesophageal Reflux Disease in Primary Care: Is There a Link?. Digestive Diseases and Sciences. 54(5). 1079–1086. 15 indexed citations

10.

Wahlqvist, P, et al.. (2008). Objective Measurement of Work Absence and On-The-Job Productivity: A Case-Control Study of US Employees With and Without Gastroesophageal Reflux Disease. Journal of Occupational and Environmental Medicine. 50(1). 25–31. 30 indexed citations

11.

Cao, Yang, Xiaoyan Yan, Xiuqiang Ma, et al.. (2008). Validation of a survey methodology for gastroesophageal reflux disease in China. BMC Gastroenterology. 8(1). 37–37. 39 indexed citations

12.

Rodrı́guez, Luis A. Garcı́a, Ana Ruigómez, Elisa Martín‐Merino, Saga Johansson, & Mari‐Ann Wallander. (2008). Relationship Between Gastroesophageal Reflux Disease and COPD in UK Primary Care. CHEST Journal. 134(6). 1223–1230. 48 indexed citations

13.

Wallander, Mari‐Ann, et al.. (2007). Dyspepsia in general practice: incidence, risk factors, comorbidity and mortality. Family Practice. 24(5). 403–411. 48 indexed citations

14.

Jansson, Catarina, Helena Nordenstedt, Mari‐Ann Wallander, et al.. (2007). Severe symptoms of gastro‐oesophageal reflux disease are associated with cardiovascular disease and other gastrointestinal symptoms, but not diabetes: a population‐based study. Alimentary Pharmacology & Therapeutics. 27(1). 58–65. 24 indexed citations

15.

Wallander, Mari‐Ann, et al.. (2007). Factors associated with adherence to drug therapy: a population-based study. European Journal of Clinical Pharmacology. 63(3). 307–314. 47 indexed citations

16.

Ruigómez, Ana, Luis A. Garcı́a Rodrı́guez, Mari‐Ann Wallander, Saga Johansson, & Roger Jones. (2006). Chest pain in general practice: incidence, comorbidity and mortality. Family Practice. 23(2). 167–174. 111 indexed citations

17.

Faresjö, Åshild, Foteini Anastasiou, Christos Lionis, et al.. (2006). Health-related quality of life of irritable bowel syndrome patients in different cultural settings. Health and Quality of Life Outcomes. 4(1). 21–21. 32 indexed citations

18.

Hollowell, Jennifer, Ana Ruigómez, Saga Johansson, Mari‐Ann Wallander, & Luis A. García‐Rodríguez. (2003). The incidence of bleeding complications associated with warfarin treatment in general practice in the United Kingdom.. PubMed. 53(489). 312–4. 36 indexed citations

19.

Ruigómez, Ana, Saga Johansson, Mari‐Ann Wallander, & Luis A. Garcı́a Rodrı́guez. (2001). Gender and drug treatment as determinants of mortality in a cohort of heart failure patients. European Journal of Epidemiology. 17(4). 329–335. 4 indexed citations

20.

Wallander, Mari‐Ann, et al.. (1997). Geographical variation in adverse event reporting rates in clinical trials. Pharmacoepidemiology and Drug Safety. 6(S3). S31–S35. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact